CVS Loses Challenge To Sentry’s Revamped Antitrust Suit

Sentry Data Systems Inc. can continue its lawsuit against CVS alleging the pharmacy chain is unlawfully forcing health care providers to use its 340B Drug Pricing Program administrator Wellpartner LLC, a Florida federal judge said on Wednesday…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s